Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-14 @ 5:04 AM
Study NCT ID:
NCT00143520
Status:
COMPLETED
Last Update Posted:
2021-05-10
First Post:
2005-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
Sponsor:
Daiichi Sankyo
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CS0011-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical monitor
Old Organization:
Daiichi Sankyo